Platelet-Activating Factor Antagonists: Scientific Background and Possible Clinical Applications

This publication has 100 references indexed in Scilit:

• Platelet‐activating factor antagonists reduce excitotoxic damage in cultured neurons from embryonic chick telencephalon and protect the rat hippocampus and neocortex from ischemic injury in vivo
  Journal of Neuroscience Research, 1993
• Expression of platelet activating factor receptor in renal tubular cell line (LLC-PK1)
  Biochemical and Biophysical Research Communications, 1992
• Existence of PAF receptors in human platelets and human lung tissue but not in the human myocardium
  American Heart Journal, 1992
• PAF-induced activation of polyphosphoinositide-hydrolyzing phospholipase C in cerebral cortex
  Biochemical and Biophysical Research Communications, 1992
• Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shock
  Life Sciences, 1992
• Effect of platelet activating factor on reticulo-endothelial system function
  Burns, 1991
• Protein kinase C and cyclic AMP modulate thrombin-induced platelet-activating factor synthesis in human endothelial cells
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1991
• Effect of a platelet activating factor antagonist (CV6209) on shock caused by temporary hepatic inflow occlusion
  Life Sciences, 1990
• Effect of a synthetic platelet activating factor on steroidogenesis of cultured porcine granulosa cells
  Life Sciences, 1990
• (±)- Trans -2-(3-methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist
  Biochemical and Biophysical Research Communications, 1988